Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 207 entries
Sorted by: Best Match Show Resources per page
[The diabetic in general practice].

Das Deutsche Gesundheitswesen

Zschornack MR, Haller H.
PMID: 5978802
Dtsch Gesundheitsw. 1966 Nov 24;21(47):2218-23.

No abstract available.

Cite
Zschornack MR, Haller H. Der Zuckerkranke in der allgemeinärztlichen Praxis. [The diabetic in general practice]. Dtsch Gesundheitsw. 1966;21(47):2218-23
Zschornack, M. R., & Haller, H. (1966). Der Zuckerkranke in der allgemeinärztlichen Praxis. [The diabetic in general practice]. Das Deutsche Gesundheitswesen, 21(47), 2218-23.
Zschornack, M R, and Haller, H. "Der Zuckerkranke in der allgemeinärztlichen Praxis." [The diabetic in general practice]. Das Deutsche Gesundheitswesen vol. 21,47 (1966): 2218-23.
Zschornack MR, Haller H. Der Zuckerkranke in der allgemeinärztlichen Praxis. [The diabetic in general practice]. Dtsch Gesundheitsw. 1966 Nov 24;21(47):2218-23. German. PMID: 5978802.
Copy Download .nbib Format: NLM
Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial.

Open forum infectious diseases

Mulligan MJ, Bernstein DI, Frey S, Winokur P, Rouphael N, Dickey M, Edupuganti S, Spearman P, Anderson E, Graham I, Noah DL, Mangal B, Kim S, Hill H, Whitaker J, Emery W, Beck A, Stephens K, Hartwell B, Ogilvie M, Rimann N, Osinski E, Destefano E, Gajadhar T, Strudwick A, Pierce K, Lai L, Yue L, Wang D, Ying C, Cline A, Foltz T, Wagner N, Dull G, Pacatte T, Taggart B, Johnson V, Haller L, Looney C, Li S, May M, Myers B, May R, Parker L, Cochran N, Bowen D, Bell M, Scoggins J, Burns A, Stablein C, Wolff M, Jolles B, Leung B, Lambert L, Shorer S, Buchanan W, Murray S, Chang S, Gorman R.
PMID: 25734170
Open Forum Infect Dis. 2014 Nov 18;1(3):ofu102. doi: 10.1093/ofid/ofu102. eCollection 2014 Dec.

BACKGROUND: Avian influenza A/H5N1 has threatened human health for nearly 2 decades. Avian influenza A vaccine without adjuvant is poorly immunogenic. A flexible rapid tactic for mass vaccination will be needed if a pandemic occurs.METHODS: A multicenter, randomized, blinded...

Cite
Mulligan MJ, Bernstein DI, Frey S, et al. Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial. Open Forum Infect Dis. 2014;1(3):ofu102doi: 10.1093/ofid/ofu102.
Mulligan, M. J., Bernstein, D. I., Frey, S., Winokur, P., Rouphael, N., Dickey, M., Edupuganti, S., Spearman, P., Anderson, E., Graham, I., Noah, D. L., Mangal, B., Kim, S., Hill, H., Whitaker, J., Emery, W., Beck, A., Stephens, K., Hartwell, B., Ogilvie, M., Rimann, N., Osinski, E., Destefano, E., Gajadhar, T., Strudwick, A., Pierce, K., Lai, L., Yue, L., Wang, D., Ying, C., Cline, A., Foltz, T., Wagner, N., Dull, G., Pacatte, T., Taggart, B., Johnson, V., Haller, L., Looney, C., Li, S., May, M., Myers, B., May, R., Parker, L., Cochran, N., Bowen, D., Bell, M., Scoggins, J., Burns, A., Stablein, C., Wolff, M., Jolles, B., Leung, B., Lambert, L., Shorer, S., Buchanan, W., Murray, S., Chang, S., & Gorman, R. (2014). Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial. Open forum infectious diseases, 1(3), ofu102. https://doi.org/10.1093/ofid/ofu102
Mulligan, Mark J, et al. "Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial." Open forum infectious diseases vol. 1,3 (2014): ofu102. doi: https://doi.org/10.1093/ofid/ofu102
Mulligan MJ, Bernstein DI, Frey S, Winokur P, Rouphael N, Dickey M, Edupuganti S, Spearman P, Anderson E, Graham I, Noah DL, Mangal B, Kim S, Hill H, Whitaker J, Emery W, Beck A, Stephens K, Hartwell B, Ogilvie M, Rimann N, Osinski E, Destefano E, Gajadhar T, Strudwick A, Pierce K, Lai L, Yue L, Wang D, Ying C, Cline A, Foltz T, Wagner N, Dull G, Pacatte T, Taggart B, Johnson V, Haller L, Looney C, Li S, May M, Myers B, May R, Parker L, Cochran N, Bowen D, Bell M, Scoggins J, Burns A, Stablein C, Wolff M, Jolles B, Leung B, Lambert L, Shorer S, Buchanan W, Murray S, Chang S, Gorman R. Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial. Open Forum Infect Dis. 2014 Nov 18;1(3):ofu102. doi: 10.1093/ofid/ofu102. eCollection 2014 Dec. PMID: 25734170; PMCID: PMC4324215.
Copy Download .nbib Format: NLM
The use of telemedicine in burn care: development of a mobile system for TBSA documentation and remote assessment.

Annals of burns and fire disasters

Parvizi D, Giretzlehner M, Dirnberger J, Owen R, Haller HL, Schintler MV, Wurzer P, Lumenta DB, Kamolz LP.
PMID: 26170783
Ann Burns Fire Disasters. 2014 Jun 30;27(2):94-100.

The requirements for accurate documentation within the process of burn assessment have increased dramatically over the years. TBSA (total body surface area) and burn depth are commonly determined by visual inspection, especially in the emergency or acute care setting....

Cite
Parvizi D, Giretzlehner M, Dirnberger J, et al. The use of telemedicine in burn care: development of a mobile system for TBSA documentation and remote assessment. Ann Burns Fire Disasters. 2014;27(2):94-100
Parvizi, D., Giretzlehner, M., Dirnberger, J., Owen, R., Haller, H. L., Schintler, M. V., Wurzer, P., Lumenta, D. B., & Kamolz, L. P. (2014). The use of telemedicine in burn care: development of a mobile system for TBSA documentation and remote assessment. Annals of burns and fire disasters, 27(2), 94-100.
Parvizi, D, et al. "The use of telemedicine in burn care: development of a mobile system for TBSA documentation and remote assessment." Annals of burns and fire disasters vol. 27,2 (2014): 94-100.
Parvizi D, Giretzlehner M, Dirnberger J, Owen R, Haller HL, Schintler MV, Wurzer P, Lumenta DB, Kamolz LP. The use of telemedicine in burn care: development of a mobile system for TBSA documentation and remote assessment. Ann Burns Fire Disasters. 2014 Jun 30;27(2):94-100. PMID: 26170783; PMCID: PMC4396802.
Copy Download .nbib Format: NLM
[No title available]

Der Internist

Fliser D, Haller H.
PMID: 28550326
Internist (Berl). 2000 Nov;41(12):1363-1373. doi: 10.1007/s001080050702.

No abstract available.

Cite
Fliser D, Haller H. Nephropathie bei Diabetes mellitus Typ 2. . Internist (Berl). 2000;41(12):1363-1373doi: 10.1007/s001080050702.
Fliser, D., & Haller, H. (2000). Nephropathie bei Diabetes mellitus Typ 2. . Der Internist, 41(12), 1363-1373. https://doi.org/10.1007/s001080050702
Fliser, D, and Haller, H. "Nephropathie bei Diabetes mellitus Typ 2." . Der Internist vol. 41,12 (2000): 1363-1373. doi: https://doi.org/10.1007/s001080050702
Fliser D, Haller H. Nephropathie bei Diabetes mellitus Typ 2. . Internist (Berl). 2000 Nov;41(12):1363-1373. doi: 10.1007/s001080050702. German. PMID: 28550326.
Copy Download .nbib Format: NLM
Trends in hospitalizations with primary varicella and herpes zoster during the prevaricella and initial postvaricella and herpes zoster vaccine eras, connecticut, 1994-2012.

Open forum infectious diseases

Humes EA, Weinberger DM, Kudish KS, Hadler JL.
PMID: 26034752
Open Forum Infect Dis. 2015 Jan 28;2(1):ofv001. doi: 10.1093/ofid/ofv001. eCollection 2015 Jan.

Background.  The introductions of the varicella vaccine in 1995 and herpes zoster (HZ) vaccine in 2006 have an ongoing potential to modify the epidemiology of both diseases. Analysis of data on hospitalizations can be conducted to examine trends in...

Cite
Humes EA, Weinberger DM, Kudish KS, et al. Trends in hospitalizations with primary varicella and herpes zoster during the prevaricella and initial postvaricella and herpes zoster vaccine eras, connecticut, 1994-2012. Open Forum Infect Dis. 2015;2(1):ofv001doi: 10.1093/ofid/ofv001.
Humes, E. A., Weinberger, D. M., Kudish, K. S., & Hadler, J. L. (2015). Trends in hospitalizations with primary varicella and herpes zoster during the prevaricella and initial postvaricella and herpes zoster vaccine eras, connecticut, 1994-2012. Open forum infectious diseases, 2(1), ofv001. https://doi.org/10.1093/ofid/ofv001
Humes, Elizabeth A, et al. "Trends in hospitalizations with primary varicella and herpes zoster during the prevaricella and initial postvaricella and herpes zoster vaccine eras, connecticut, 1994-2012." Open forum infectious diseases vol. 2,1 (2015): ofv001. doi: https://doi.org/10.1093/ofid/ofv001
Humes EA, Weinberger DM, Kudish KS, Hadler JL. Trends in hospitalizations with primary varicella and herpes zoster during the prevaricella and initial postvaricella and herpes zoster vaccine eras, connecticut, 1994-2012. Open Forum Infect Dis. 2015 Jan 28;2(1):ofv001. doi: 10.1093/ofid/ofv001. eCollection 2015 Jan. PMID: 26034752; PMCID: PMC4438882.
Copy Download .nbib Format: NLM
Oxidation of Electron Donor-Substituted Verdazyls: Building Blocks for Molecular Switches.

The journal of physical chemistry. A

Haller BC, Chambers D, Cheng R, Chemistruck V, Hom TF, Li Z, Nguyen J, Ichimura A, Brook DJ.
PMID: 26451688
J Phys Chem A. 2015 Oct 29;119(43):10750-60. doi: 10.1021/acs.jpca.5b09295. Epub 2015 Oct 20.

Species that can undergo changes in electronic configuration as a result of an external stimulus such as pH or solvent polarity can play an important role in sensors, conducting polymers, and molecular switches. One way to achieve such structures...

Cite
Haller BC, Chambers D, Cheng R, et al. Oxidation of Electron Donor-Substituted Verdazyls: Building Blocks for Molecular Switches. J Phys Chem A. 2015;119(43):10750-60doi: 10.1021/acs.jpca.5b09295.
Haller, B. C., Chambers, D., Cheng, R., Chemistruck, V., Hom, T. F., Li, Z., Nguyen, J., Ichimura, A., & Brook, D. J. (2015). Oxidation of Electron Donor-Substituted Verdazyls: Building Blocks for Molecular Switches. The journal of physical chemistry. A, 119(43), 10750-60. https://doi.org/10.1021/acs.jpca.5b09295
Haller, Benjamin C, et al. "Oxidation of Electron Donor-Substituted Verdazyls: Building Blocks for Molecular Switches." The journal of physical chemistry. A vol. 119,43 (2015): 10750-60. doi: https://doi.org/10.1021/acs.jpca.5b09295
Haller BC, Chambers D, Cheng R, Chemistruck V, Hom TF, Li Z, Nguyen J, Ichimura A, Brook DJ. Oxidation of Electron Donor-Substituted Verdazyls: Building Blocks for Molecular Switches. J Phys Chem A. 2015 Oct 29;119(43):10750-60. doi: 10.1021/acs.jpca.5b09295. Epub 2015 Oct 20. PMID: 26451688.
Copy Download .nbib Format: NLM
[A population model of the SPES-project--a microanalytic simulation model for the forecasting of family and household structures].

Allgemeines statistisches Archiv

Galler HP.
PMID: 12337754
All Stat Arch. 1977;61(4):371-90.

No abstract available.

Cite
Galler HP. Das Bevolkerungsmodell des SPES-Projekts--ein Modell auf Individualdatenbasis zur Vorausschatzung von Familien- und Haushaltsstrukturen [A population model of the SPES-project--a microanalytic simulation model for the forecasting of family and household structures]. All Stat Arch. 1977;61(4):371-90
Galler, H. P. (1977). Das Bevolkerungsmodell des SPES-Projekts--ein Modell auf Individualdatenbasis zur Vorausschatzung von Familien- und Haushaltsstrukturen [A population model of the SPES-project--a microanalytic simulation model for the forecasting of family and household structures]. Allgemeines statistisches Archiv, 61(4), 371-90.
Galler, H P. "Das Bevolkerungsmodell des SPES-Projekts--ein Modell auf Individualdatenbasis zur Vorausschatzung von Familien- und Haushaltsstrukturen" [A population model of the SPES-project--a microanalytic simulation model for the forecasting of family and household structures]. Allgemeines statistisches Archiv vol. 61,4 (1977): 371-90.
Galler HP. Das Bevolkerungsmodell des SPES-Projekts--ein Modell auf Individualdatenbasis zur Vorausschatzung von Familien- und Haushaltsstrukturen [A population model of the SPES-project--a microanalytic simulation model for the forecasting of family and household structures]. All Stat Arch. 1977;61(4):371-90. German. PMID: 12337754.
Copy Download .nbib Format: NLM
(n,m) Abundance evaluation of single-walled carbon nanotubes by fluorescence and absorption spectroscopy.

Journal of the American Chemical Society

Luo Z, Pfefferle LD, Haller GL, Papadimitrakopoulos F.
PMID: 17132018
J Am Chem Soc. 2006 Dec 06;128(48):15511-6. doi: 10.1021/ja0657096.

A methodology that takes into account the (n,m) structure of single-walled carbon nanotubes (SWNTs), through an exciton-exciton resonance model and an electron-phonon interaction model, was employed in order to evaluate the semiconducting (n,m) abundance of two SWNT samples (i.e.,...

Cite
Luo Z, Pfefferle LD, Haller GL, et al. (n,m) Abundance evaluation of single-walled carbon nanotubes by fluorescence and absorption spectroscopy. J Am Chem Soc. 2006;128(48):15511-6doi: 10.1021/ja0657096.
Luo, Z., Pfefferle, L. D., Haller, G. L., & Papadimitrakopoulos, F. (2006). (n,m) Abundance evaluation of single-walled carbon nanotubes by fluorescence and absorption spectroscopy. Journal of the American Chemical Society, 128(48), 15511-6. https://doi.org/10.1021/ja0657096
Luo, Zhengtang, et al. "(n,m) Abundance evaluation of single-walled carbon nanotubes by fluorescence and absorption spectroscopy." Journal of the American Chemical Society vol. 128,48 (2006): 15511-6. doi: https://doi.org/10.1021/ja0657096
Luo Z, Pfefferle LD, Haller GL, Papadimitrakopoulos F. (n,m) Abundance evaluation of single-walled carbon nanotubes by fluorescence and absorption spectroscopy. J Am Chem Soc. 2006 Dec 06;128(48):15511-6. doi: 10.1021/ja0657096. PMID: 17132018.
Copy Download .nbib Format: NLM
Synthesis, characterization, and stability of Fe-MCM-41 for production of carbon nanotubes by acetylene pyrolysis.

The journal of physical chemistry. B

Amama PB, Lim S, Ciuparu D, Yang Y, Pfefferle L, Haller GL.
PMID: 16851270
J Phys Chem B. 2005 Feb 24;109(7):2645-56. doi: 10.1021/jp047158g.

Fe-substituted MCM-41 molecular sieves with ca. 1, 2, and 3 wt % Fe were synthesized hydrothermally using different sources of colloidal silica (HiSil and Cab-O-Sil) and characterized by ICP, XRD, N2 physisorption, UV-vis, EPR, TPR, and X-ray absorption. Catalysts...

Cite
Amama PB, Lim S, Ciuparu D, et al. Synthesis, characterization, and stability of Fe-MCM-41 for production of carbon nanotubes by acetylene pyrolysis. J Phys Chem B. 2005;109(7):2645-56doi: 10.1021/jp047158g.
Amama, P. B., Lim, S., Ciuparu, D., Yang, Y., Pfefferle, L., & Haller, G. L. (2005). Synthesis, characterization, and stability of Fe-MCM-41 for production of carbon nanotubes by acetylene pyrolysis. The journal of physical chemistry. B, 109(7), 2645-56. https://doi.org/10.1021/jp047158g
Amama, Placidus B, et al. "Synthesis, characterization, and stability of Fe-MCM-41 for production of carbon nanotubes by acetylene pyrolysis." The journal of physical chemistry. B vol. 109,7 (2005): 2645-56. doi: https://doi.org/10.1021/jp047158g
Amama PB, Lim S, Ciuparu D, Yang Y, Pfefferle L, Haller GL. Synthesis, characterization, and stability of Fe-MCM-41 for production of carbon nanotubes by acetylene pyrolysis. J Phys Chem B. 2005 Feb 24;109(7):2645-56. doi: 10.1021/jp047158g. PMID: 16851270.
Copy Download .nbib Format: NLM
Treatment of functional dyspepsia.

Current treatment options in gastroenterology

Halder SL, Talley NJ.
PMID: 16009034
Curr Treat Options Gastroenterol. 2005 Aug;8(4):325-36. doi: 10.1007/s11938-005-0026-8.

Functional dyspepsia (FD) is a common reason a patient presents with upper gastrointestinal symptoms for medical care. Although treatment of FD remains expensive, the agents are rarely used in a systematic manner; the majority of treatments are empirical and...

Cite
Halder SL, Talley NJ. Treatment of functional dyspepsia. Curr Treat Options Gastroenterol. 2005;8(4):325-36doi: 10.1007/s11938-005-0026-8.
Halder, S. L., & Talley, N. J. (2005). Treatment of functional dyspepsia. Current treatment options in gastroenterology, 8(4), 325-36. https://doi.org/10.1007/s11938-005-0026-8
Halder, Smita L S, and Talley, Nicholas J. "Treatment of functional dyspepsia." Current treatment options in gastroenterology vol. 8,4 (2005): 325-36. doi: https://doi.org/10.1007/s11938-005-0026-8
Halder SL, Talley NJ. Treatment of functional dyspepsia. Curr Treat Options Gastroenterol. 2005 Aug;8(4):325-36. doi: 10.1007/s11938-005-0026-8. PMID: 16009034.
Copy Download .nbib Format: NLM
[Fibrosing diseases.].

Der Internist

Haller H, Gross WL.
PMID: 20077106
Internist (Berl). 2010 Jan;51(1):5. doi: 10.1007/s00108-009-2562-0.

No abstract available.

Cite
Haller H, Gross WL. Fibrosierende Erkrankungen. [Fibrosing diseases.]. Internist (Berl). 2010;51(1):5doi: 10.1007/s00108-009-2562-0.
Haller, H., & Gross, W. L. (2010). Fibrosierende Erkrankungen. [Fibrosing diseases.]. Der Internist, 51(1), 5. https://doi.org/10.1007/s00108-009-2562-0
Haller, H, and Gross, W L. "Fibrosierende Erkrankungen." [Fibrosing diseases.]. Der Internist vol. 51,1 (2010): 5. doi: https://doi.org/10.1007/s00108-009-2562-0
Haller H, Gross WL. Fibrosierende Erkrankungen. [Fibrosing diseases.]. Internist (Berl). 2010 Jan;51(1):5. doi: 10.1007/s00108-009-2562-0. German. PMID: 20077106.
Copy Download .nbib Format: NLM
Colorectal cancer treatment in the elderly: tailored therapy approaches.

Gastrointestinal cancer research : GCR

Avadhani AN, Haller DG.
PMID: 19262904
Gastrointest Cancer Res. 2007 Nov;1(6):254-5.

No abstract available.

Cite
Avadhani AN, Haller DG. Colorectal cancer treatment in the elderly: tailored therapy approaches. Gastrointest Cancer Res. 2007;1(6):254-5
Avadhani, A. N., & Haller, D. G. (2007). Colorectal cancer treatment in the elderly: tailored therapy approaches. Gastrointestinal cancer research : GCR, 1(6), 254-5.
Avadhani, Anjali N, and Haller, Daniel G. "Colorectal cancer treatment in the elderly: tailored therapy approaches." Gastrointestinal cancer research : GCR vol. 1,6 (2007): 254-5.
Avadhani AN, Haller DG. Colorectal cancer treatment in the elderly: tailored therapy approaches. Gastrointest Cancer Res. 2007 Nov;1(6):254-5. PMID: 19262904; PMCID: PMC2631217.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 207 entries